Clinical Trial Update: Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates safety, efficacy, PK, and PD of the orally inhaled SB010 in male adults with mild asthma, based on a multiple-dose study update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SB010

Snippet

Sponsor: Sterna Biologicals GmbH & Co. KG | Conditions: Asthma | Phase 2 | Status: COMPLETED